UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

The lancet oncology, 2016-07, Vol.17 (7), p.956-965

2016

Volltextzugriff (PDF)

Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy

Science (American Association for the Advancement of Science), 2018-10, Vol.362 (6411)

2018

Volltextzugriff (PDF)

Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors

Journal of clinical oncology, 2015-10, Vol.33 (29), p.3227-3234

2015

Volltextzugriff (PDF)

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study

Journal of clinical oncology, 2017-05, Vol.35 (14), p.1542-1549

2017

Volltextzugriff (PDF)

PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer

Clinical cancer research, 2017-06, Vol.23 (12), p.3158-3167

2017

Volltextzugriff (PDF)

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

Clinical cancer research, 2015-02, Vol.21 (3), p.632-641

2015

Volltextzugriff (PDF)

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

Clinical cancer research, 2015-02, Vol.21 (4), p.870-881

2015

Volltextzugriff (PDF)

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer

Clinical cancer research, 2019-09, Vol.25 (17), p.5315-5328

2019

Volltextzugriff (PDF)

mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas

Clinical cancer research, 2012-05, Vol.18 (9), p.2558-2568

2012

Volltextzugriff (PDF)

Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis

Frontiers in immunology, 2021-04, Vol.12, p.645170-645170

2021

Volltextzugriff (PDF)

Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement

The Laryngoscope, 2024-02, Vol.134 (2), p.577-581

2024

Volltextzugriff (PDF)

Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma

Journal for immunotherapy of cancer, 2022-02, Vol.10 (2), p.e003026

2022

Volltextzugriff (PDF)

The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (7), p.3021-3031

2009

Volltextzugriff (PDF)

Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2016-09, Vol.96 (1), p.21-29

2016

Volltextzugriff (PDF)

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

The lancet oncology, 2009-03, Vol.10 (3), p.247-257

2009

Volltextzugriff (PDF)

Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience

Oral oncology, 2018-05, Vol.80, p.16-22

2018

Volltextzugriff (PDF)

HPV-Associated Head and Neck Cancer

JNCI : Journal of the National Cancer Institute, 2015-12, Vol.107 (12), p.djv344-djv344

2015

Volltextzugriff (PDF)

The role of macrophages in the tumor microenvironment and tumor metabolism

Seminars in immunopathology, 2023-03, Vol.45 (2), p.187-201

2023

Volltextzugriff (PDF)

A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Clinical cancer research, 2012-04, Vol.18 (8), p.2336-2343

2012

Volltextzugriff (PDF)

Molecular pathways in head and neck cancer: EGFR, PI3K, and more

American Society of Clinical Oncology educational book, 2013, Vol.33, p.246-255

2013

Volltextzugriff (PDF)

Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma

NPJ precision oncology, 2023-04, Vol.7 (1), p.36-36, Article 36

2023

Volltextzugriff (PDF)

Are taxanes the future for head and neck cancer? Pragmatism in the immunotherapy era

The lancet oncology, 2021-04, Vol.22 (4), p.413-415

2021

Volltextzugriff (PDF)

Single sample expression-anchored mechanisms predict survival in head and neck cancer

PLoS computational biology, 2012-01, Vol.8 (1), p.e1002350-e1002350

2012

Volltextzugriff (PDF)

Deintensification of treatment for human papillomavirus-related oropharyngeal cancer: Current state and future directions

Oral oncology, 2020-06, Vol.105, p.104652-104652, Article 104652

2020

Volltextzugriff (PDF)

IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade

The Journal of clinical investigation, 2017-08, Vol.127 (8), p.2930-2940

2017

Volltextzugriff (PDF)

1 – 25 von 205

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(198)
Mit Volltextzugriff
(197)

Publikationsform

Sprache

Englisch
(205)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(97)
Life Sciences & Biomedicine
(95)
Humans
(87)
Oncology
(75)
Female
(43)
Male
(41)
Head And Neck Neoplasms - Drug Therapy
(36)
Middle Aged
(34)
Tumors
(33)
Aged
(32)
Head & Neck Cancer
(29)
Adult
(28)
Squamous Cell Carcinoma
(28)
Immunotherapy
(25)
Otorhinolaryngology
(21)
Aged, 80 And Over
(19)
Head And Neck Neoplasms - Pathology
(18)
Mutation
(18)
Carcinoma, Squamous Cell - Drug Therapy
(17)
Squamous Cell Carcinoma Of Head And Neck
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy

Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study

PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer

mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas

Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis

Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement

Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma

The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma

Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience

HPV-Associated Head and Neck Cancer

The role of macrophages in the tumor microenvironment and tumor metabolism

A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Molecular pathways in head and neck cancer: EGFR, PI3K, and more

Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma

Are taxanes the future for head and neck cancer? Pragmatism in the immunotherapy era

Single sample expression-anchored mechanisms predict survival in head and neck cancer

Deintensification of treatment for human papillomavirus-related oropharyngeal cancer: Current state and future directions

IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade

Suchergebnisse filtern